David Owens - Sep 16, 2022 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Role: Chief Medical Officer, Director
Signature: /s/ David Owens Name: David Owens, M.D.
Stock symbol: NXL
Transactions as of: Sep 16, 2022
Transactions value $: $10,375
Form type: 4
Date filed: 9/20/2022, 02:05 PM
Previous filing: Sep 19, 2022
Next filing: Jun 12, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXL	Common Stock	Purchase	$10.4K	+2.5K	+1.8%	$4.15^*	141K	Sep 16, 2022	Direct

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David Owens is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Includes shares owed by LTB Investment Holdings LLC. Reporting Person has voting and dispositive control of the shares owned by LTB Investment Holdings LLC. Reporting Person has executed this Form 4 on behalf of himself and LTB Investment Holdings LLC